[Increased menstrual bleeding among direct oral anticoagulant users].

Ned Tijdschr Geneeskd

Rivas Zorggroep, locatie Beatrixziekenhuis, Gorinchem. Afd. Interne Geneeskunde.

Published: May 2023

Background: Two-thirds of users of oral anticoagulants use direct oral anticoagulants, among which increasingly women in their reproductive age. The risk of severe or abnormal menstrual bleeding doubles to 70% when using anticoagulants. With rivaroxaban especially the risk seems higher than with vitamin K antagonists; with dabigatran possibly lower.

Case Description: We saw a 49-year-old woman who started the oral contraceptive pill because of heavy menstrual bleeding. After getting deep vein thrombosis we stopped the pill and started rivaroxaban. Despite leuproreline the heavy bleeding persisted and 6 blood transfusions were necessary, after which the type of anticoagulant was changed. Eventually, we performed a hysterectomy.

Conclusion: Anticoagulants can cause severe menstrual bleeding, especially in women with a history of heavy menstrual periods. The type of anticoagulant can be changed and the bleeding can be treated by both hormonal and non-hormonal therapies.

Download full-text PDF

Source

Publication Analysis

Top Keywords

menstrual bleeding
16
direct oral
8
oral anticoagulants
8
heavy menstrual
8
type anticoagulant
8
anticoagulant changed
8
bleeding
6
[increased menstrual
4
bleeding direct
4
oral
4

Similar Publications

Uterine leiomyoma, also referred to as fibroid or myoma, is a prevalent benign tumor that can present with a range of clinical manifestations. The symptoms, which vary based on the tumor's location, size, and number, include pain, constipation, urinary disturbances, and abnormal menstrual bleeding. Certain types of uterine leiomyomas, such as pedunculated subserosal myomas or large degenerating cystic myomas, may closely mimic ovarian tumors, leading to significant diagnostic and management challenges.

View Article and Find Full Text PDF

Objective: We sought to develop consensus recommendations for measurement and analysis of data on contraceptive-induced menstrual changes (CIMCs) in contraceptive clinical trials. We built upon previous standardization efforts over the last 50 years and prioritized input from a variety of global experts and current regulatory authority guidance on patient-reported outcomes.

Study Design: We completed a formal consensus-building process with an interdisciplinary group of 57 experts from 30 organizations and 14 countries in five global regions who work across academia, nonprofit research organizations, the pharmaceutical industry, and funding agencies.

View Article and Find Full Text PDF

Abnormal Uterine Bleeding Among Rural Adolescent Schoolgirls: A Cross-Sectional Study.

Medicina (Kaunas)

December 2024

Department of Obstetrics and Gynecology, College of Medicine, Qassim University, Buraydah 52571, Saudi Arabia.

: The International Federation of Gynecology and Obstetrics (FIGO) and the American College of Obstetricians and Gynecologists (ACOG) define abnormal uterine bleeding (AUB) as "bleeding from the uterus that is abnormal in regularity, volume, frequency, or duration and occurs in the absence of pregnancy". The impact of AUB on the physical and psychosocial well-being of adolescent girls can be significant. In this study, we aim to investigate the menstrual cycle characteristics in adolescent Sudanese schoolgirls and the prevalence of abnormal uterine bleeding (AUB) and its associated factors.

View Article and Find Full Text PDF

Objective: Little is known about the role of timing of physical activity in female reproductive disorders. These disorders include polycystic ovary syndrome (PCOS), heavy menstrual bleeding (HMB), endometriosis, infertility, and pregnancy-related disorders. This study aims to investigate the associations of activity patterns with female reproductive diseases.

View Article and Find Full Text PDF

Introduction: This study explored the effects of four different surgical methods in the treatment of cesarean scar pregnancy (CSP).

Methods: In this multicenter retrospective analysis of 359 patients, the surgical indices, the time taken for the serum human chorionic gonadotropin level to return to normal, the recovery time of menstruation, and the incidence of postoperative adverse reactions were comparatively analyzed. The clinical efficacies of various preoperative treatment methods to block the blood supply to CSP tissues and those of four different surgical methods to treat CSP, namely, curettage, hysteroscopic surgery, laparoscopic surgery, and vaginal surgery, were evaluated in this study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!